In the present study we assess anti-SARS-CoV-2 spike (S) protein antibodies (IgM, IgG, and IgG subclasses) and neutralizing antibody titers in serum obtained at the time of admission from a cohort of unvaccinated patients hospitalized for coronavirus disease 2019 (COVID-19). The gene discussed is CD40LG; the disease is COVID-19.